IRVINGTON, N.Y., Oct. 16, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, today announced that the company will be participating in the 32nd Annual Fall Clinical Dermatology Conference taking place October 17 – 20, 2013 in Las Vegas, Nevada. The Fall Clinical Dermatology Conference is a four-day sold-out medical conference that is well attended by over 500 dermatologists, dermatology residents, fellows, physician assistants and nurse practitioners. The...
↧